Skip to main content

Market Overview

22 Stocks Moving in Monday's Pre-Market Session

Share:
22 Stocks Moving in Monday's Pre-Market Session

Gainers

  • Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn ImmunoTherapeutics. The company, on April 26, entered into a purchase agreement with Lincoln Park Capital Fund under which the company may sell up to $200 million of common stock to Lincoln Park.
  • Regional Health Properties, Inc. (NYSE: RHE) rose 24.2% to $8.97 in pre-market trading after jumping 38% on Friday.
  • Gaucho Group Holdings, Inc. (NASDAQ: VINO) rose 17.5% to $5.10 in pre-market trading after climbing 19% on Friday.
  • Vaxart, Inc. (NASDAQ: VXRT) rose 15.6% to $12.46 in pre-market trading after adding 17% in the previous session.
  • Ashford Hospitality Trust, Inc. (NYSE: AHT) shares rose 13.2% to $3.10 in pre-market trading after jumping over 13% on Friday.
  • Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 12.2% to $12.84 in pre-market trading after dropping over 5% on Friday.
  • Meredith Corporation (NYSE: MDP) rose 11.9% to $34.80 in pre-market trading. The company, last week, reported Q3 results.
  • BriaCell Therapeutics Corp. (NASDAQ: BCTX) rose 11.1% to $4.10 in pre-market trading after gaining more than 6% on Friday.
  • Farmmi, Inc. (NASDAQ: FAMI) rose 7.9% to $0.4810 in pre-market trading after jumping around 25% on Friday. The company, last week, announced it priced its 140 million common stock offering $0.30 per share.
  • GeoVax Labs, Inc. (NASDAQ: GOVX) shares rose 7.7% to $5.86 in pre-market trading. GeoVax is expected to report Q1 results on May 6.
  • Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares rose 7.6% to $4.27 in pre-market trading. Virpax Pharmaceuticals, last week, said it engaged Torreya Capital to advise on global partnering efforts.
  • DAVIDsTEA Inc. (NASDAQ: DTEA) rose 7.5% to $3.60 in pre-market trading following quarterly results. The company reported Q4 adjusted earnings of $0.15 per share, up from $0.13 per share in the year-ago quarter. Its total sales fell 45.3% to $40.2 million, while sales from e-commerce and wholesale channels jumped by 95.9% during the quarter.
  • Novan, Inc. (NASDAQ: NOVN) rose 7.3% to $1.47 in pre-market trading. Roth Capital, last week, initiated coverage on the stock with a Buy rating and announced a $3 price target.
  • Protalix BioTherapeutics, Inc. (NYSE: PLX) rose 7.2% to $3.59 in pre-market trading. The company, last week, announced it received a Complete Response Letter for its Pegunigalsidase Alfa as a treatment for Fabry disease from the FDA.
  • U.S. Well Services, Inc. (NASDAQ: USWS) shares rose 7.1% to $0.88 in pre-market trading after declining 6% on Friday.
  • Adverum Biotechnologies, Inc. (NASDAQ: ADVM) rose 5.9% to $4.13 in pre-market trading as the company announced new long-term data from the OPTIC Phase 1 trial of ADVM-022 single intravitreal (IVT) injection gene therapy in patients with neovascular or wet age-related macular degeneration (wet AMD).
  • AbCellera Biologics Inc. (NASDAQ: ABCL) rose 5.1% to $28.00 in pre-market trading. The company is scheduled to release Q1 results on May 13.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 5.5% to $6.16 in pre-market trading. Image Sensing Systems shares jumped 42% on Friday after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000 share buyback and announced the implementation of a holding company reorganization.
  • Salem Media Group, Inc. (NASDAQ: SALM) shares fell 5.5% to $1.90 in pre-market trading after dropping over 4% on Friday.
  • Torchlight Energy Resources, Inc. (NASDAQ: TRCH) fell 5% to $2.01 in pre-market trading after dropping around 9% on Friday.
  • Sanofi (NASDAQ: SNY) fell 4.5% to $50.02 in pre-market trading.
  • Plus Therapeutics, Inc. (NASDAQ: PSTV) fell 4.4% to $2.18 in pre-market trading. Plus Therapeutics, last month, reported a Q1 loss of $0.33 per share.
 

Related Articles (ADVM + ABCL)

View Comments and Join the Discussion!

Posted-In: Pre-Market MoversNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com